semaglutide and atrial fibrillation AFib: Heart Safety for Weight Loss GLP-1 Weight Loss & AFib

Long-term safety data from real-world use and extended trials shows that most patients tolerate semaglutide well beyond the initial 12-month period

Intravenous (IV) Therapy & Injections IV NAD+: The ultimate cellular "recharge" for anti-aging, brain health, and metabolic speed

The use of lorcaserin is associated with an additional annual weight loss of about 3.23.6 kg as well as improvements in metabolic parameters including blood pressure (systolic, 0.61 mmHg

The Quiet Shortcut in GLP-1 Care There is a growing pattern in modern metabolic care that deserves closer scrutiny: thousands of patients are now being prescribed GLP-1 medications without ever completing a basic set of laboratory tests

Some discount programs may also be available through manufacturers

Abstract The present study evaluated the effects of physiological serum estrogen during the menstrual cycle on glutathione (GSH) and catalase activities